These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24204912)

  • 1. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.
    Leung V; Gillis J; Raboud J; Cooper C; Hogg RS; Loutfy MR; Machouf N; Montaner JS; Rourke SB; Tsoukas C; Klein MB;
    PLoS One; 2013; 8(10):e77665. PubMed ID: 24204912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.
    Ndumbi P; Gillis J; Raboud J; Cooper C; Hogg RS; Montaner JS; Burchell AN; Loutfy MR; Machouf N; Klein MB; Tsoukas C;
    HIV Med; 2014 Mar; 15(3):153-64. PubMed ID: 24304582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
    PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
    Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
    Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy.
    Okhai H; Vivancos-Gallego MJ; Hill T; Sabin CA
    AIDS Res Hum Retroviruses; 2020 Oct; 36(10):808-816. PubMed ID: 32664736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.
    Chereau F; Madec Y; Sabin C; Obel N; Ruiz-Mateos E; Chrysos G; Fidler S; Lehmann C; Zangerle R; Wittkop L; Reiss P; Hamouda O; Estrada Perez V; Leal M; Mocroft A; Garcia De Olalla P; Ammassari A; D'Arminio Monforte A; Mussini C; Segura F; Castagna A; Cavassini M; Grabar S; Morlat P; De Wit S; Lambotte O; Meyer L;
    PLoS One; 2017; 12(4):e0173893. PubMed ID: 28380038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline CD4/CD8 T-Cell Ratio Predicts Prompt Immune Restoration Upon cART Initiation.
    Bellissimo F; Pinzone MR; Celesia BM; Cacopardo B; Nunnari G
    Curr HIV Res; 2016; 14(6):491-496. PubMed ID: 27074946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of suboptimal CD4
    Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
    J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy.
    Erlandson KM; Allshouse AA; Jankowski CM; Lee EJ; Rufner KM; Palmer BE; Wilson CC; MaWhinney S; Kohrt WM; Campbell TB
    J Infect Dis; 2013 Jul; 208(2):249-59. PubMed ID: 23559466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Patients With Human Immunodeficiency Virus Infection and Suppressed Viremia During Long-term Antiretroviral Therapy.
    Mutoh Y; Nishijima T; Inaba Y; Tanaka N; Kikuchi Y; Gatanaga H; Oka S
    Clin Infect Dis; 2018 Aug; 67(6):927-933. PubMed ID: 29509894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticity of the Immune System in Children Following Treatment Interruption in HIV-1 Infection.
    Sandgaard KS; Margetts B; Attenborough T; Gkouleli T; Adams S; Holm M; Gibb D; Gibbons D; Giaquinto C; De Rossi A; Bamford A; Palma P; Chain B; Gkazi AS; Klein N
    Front Immunol; 2021; 12():643189. PubMed ID: 34475868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.
    Poizot-Martin I; Faucher O; Obry-Roguet V; Nicolino-Brunet C; Ronot-Bregigeon S; Dignat-George F; Tamalet C
    J Clin Virol; 2013 Aug; 57(4):351-5. PubMed ID: 23664725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delay in cART initiation results in persistent immune dysregulation and poor recovery of T-cell phenotype despite a decade of successful HIV suppression.
    Ndumbi P; Falutz J; Pant Pai N; Tsoukas CM
    PLoS One; 2014; 9(4):e94018. PubMed ID: 24710051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines.
    Zhabokritsky A; Szadkowski L; Cooper C; Loutfy M; Wong A; McClean A; Hogg RS; Walmsley SL;
    J Antimicrob Chemother; 2021 Feb; 76(3):729-737. PubMed ID: 33249444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
    Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
    AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverted CD4+/CD8+ ratio associated with AIDS event and death in HIV-1 infected individuals in Nasarawa State, Nigeria.
    Forbi JC; Agwale SM
    Tanzan J Health Res; 2009 Jul; 11(3):144-8. PubMed ID: 20734711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.
    Hunt PW; Cao HL; Muzoora C; Ssewanyana I; Bennett J; Emenyonu N; Kembabazi A; Neilands TB; Bangsberg DR; Deeks SG; Martin JN
    AIDS; 2011 Nov; 25(17):2123-31. PubMed ID: 21881481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.
    Nakanjako D; Ssinabulya I; Nabatanzi R; Bayigga L; Kiragga A; Joloba M; Kaleebu P; Kambugu AD; Kamya MR; Sekaly R; Elliott A; Mayanja-Kizza H
    Trop Med Int Health; 2015 Mar; 20(3):380-90. PubMed ID: 25441397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell counts in primary HIV infection predicts disease progression and immune restoration after treatment.
    Wang Y; Zhang Y; Tang T; Zhao W; Fu S; Zhang Z; Fu Y; Xu J; Ding H; Han X; Jiang Y
    Virology; 2020 Nov; 550():89-98. PubMed ID: 32920454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.